Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
MoonLake Immunotherapeutics has filed 316 SEC EDGAR filings since 28 Aug 2020

SEC filing history

Showing 176-200 of 316 matching filings.

Per page
25
Current page
8
CORRESP

CORRESP filing

Filing date
05 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262643

EFFECT filing

Filing date
04 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
04 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-271546

S-3

Filing date
01 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-262643

POS AM

Filing date
01 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39630

ARS

Filing date
26 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39630

FORM DEFA14A

Filing date
26 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39630

DEF 14A

Filing date
26 Apr 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
19 Apr 2023
Reporting date
19 Apr 2023
Next action
Verify source filing
4

4 filing

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91803

SC 13G filing

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-262643

424B3

Filing date
28 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262643

EFFECT filing

Filing date
27 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Mar 2023
Reporting date
20 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
10 Mar 2023
Reporting date
10 Mar 2023
Next action
Verify source filing
SC 13G/A File 005-91803

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91803

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91803

SC 13G/A filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91803

MOONLAKE IMMUNOTHERAPEUTICS

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91803

SC 13G/A

Filing date
27 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-262643

PROSPECTUS SUPPLEMENT

Filing date
14 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .